US$4.134 billion sales and US$1.70 adjusted EPS in Q3

Kimberly-Clark delivered stronger adjusted earnings from continuing operations in the third quarter, but organic sales and adjusted operating profit weakened as China disruption, pricing pressure and costs weighed on results. The company reaffirmed its 2026 outlook while beginning life as a larger consumer-health group after completing its Kenvue acquisition.

  • US$4.134 billion quarterly sales, down 0.4%
  • Adjusted EPS from continuing operations rose 17.2% to US$1.70
  • Organic sales declined 1.3%, including a 270 basis point China headwind
  • Kenvue acquisition costs reached US$106 million in the quarter
  • 2026 organic sales, profit and EPS outlook reaffirmed
An image related to Kimberly-Clark Corporation Add us as a preferred source on Google
Image © middle. Logo © respective owner.

Kimberly-Clark Corporation (NASDAQ:KMB) is asking investors to look past a noisy quarter. Adjusted earnings from continuing operations rose 17.2% to US$1.70 a share, but organic sales fell 1.3% and adjusted operating profit slipped 0.9% to US$677 million as China-related disruption, pricing pressure and supply-chain investment offset productivity gains.

Sales pressure remains concentrated in international personal care

Third-quarter net sales were US$4.134 billion, down 0.4% from a year earlier. Kimberly-Clark said the result included an approximately 270 basis point drag from a China social-media disruption, together with retailer inventory movements in North America. The impact was most severe in International Personal Care, where organic sales dropped 4.6% and operating profit fell 32.7% to US$144 million.

North America provided the counterweight. Segment sales increased 0.9% to US$2.738 billion, with organic growth of 0.4% driven by volume, while operating profit rose 2.7% to US$657 million. The company said increased promotional activity reduced pricing, and retailer inventory movements represented an approximately 130 basis point headwind to the region’s volume performance.

Kenvue deal changes the earnings comparison

The quarter also marks the first results period after Kimberly-Clark completed its Kenvue acquisition earlier this week. The transaction had been outlined in the Kenvue deal completion, and Kimberly-Clark recorded US$106 million of acquisition-related costs in the quarter, contributing to reported operating profit of US$516 million, down 16.9%.

Reported diluted earnings per share attributable to Kimberly-Clark surged to US$5.37 from US$1.34, but the headline gain was dominated by a roughly US$1.4 billion pre-tax gain from completing the International Family Care and Professional transaction, which is now treated as discontinued operations. Adjusted EPS attributable to Kimberly-Clark was US$1.70, down 6.6%, a measure that strips out the transaction gain, separation costs and other specified items.

Outlook survives, but integration becomes the test

Kimberly-Clark reaffirmed its 2026 expectations for organic sales growth to run approximately 100 basis points below weighted average category growth, which the company puts at about 1.7% on a trailing twelve-month basis. It continues to expect adjusted operating profit to grow at a mid-single-digit rate and adjusted EPS from continuing operations to rise at a high-single-digit rate, all on a constant-currency basis. Adjusted EPS attributable to Kimberly-Clark is still expected to decline by a low-single-digit percentage.

Cash from operations reached US$2.4 billion in the first nine months, up from US$1.8 billion, while total debt from continuing operations fell to US$6.5 billion from US$7.2 billion at the end of 2025. That balance-sheet progress sits alongside the costs and execution demands of integrating Kenvue, while the China disruption continues to obscure the underlying trajectory of the international business. The next few quarters will show whether productivity savings can do more than cushion those pressures.

Get NASDAQ:KMB news the moment it breaks

Instant push notifications No waitlist Free
Download on the App Store iPhone & iPad
Get it on Google Play Android
Email alerts

Bottom Line?

The outlook is intact, but the quality of the next earnings gains will depend on China recovery, pricing discipline and the early economics of Kenvue integration.

Questions in the middle?

  • How quickly can International Personal Care recover from the China social-media disruption?
  • Will Kenvue integration costs and capital spending remain within the company’s stated programme expectations?
  • Can productivity savings offset pricing pressure and cost inflation without relying on lower marketing or other temporary benefits?

Sources

1